Aggressive pituitary tumours and carcinomas: two sides of the same coin?-Reference-Cited by-同舟云学术

Aggressive pituitary tumours and carcinomas: two sides of the same coin?

Published:2018-06 Issue:6 Volume:178 Page:C7-C9
ISSN:0804-4643
Container-title:European Journal of Endocrinology
language:
Short-container-title:

Author:

Trouillas Jacqueline¹,Burman Pia²³,McCormack Ann⁴⁵,Petersenn Stephan⁶,Popovic Vera⁷,Dekkers Olaf⁸,Raverot Gerald¹⁹

Affiliation:

1. 1Faculté de Médecine Lyon Est, Université Lyon 1, Lyon, France

2. 2Endocrinology, Skåne University Hospital, Malmo, Sweden

3. 3Endocrinology, University of Lund, Malmo, Sweden

4. 4Department of Endocrinology, St Vincent’s Hospital, Sydney, New South Wales, Australia

5. 5Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

6. 6Center for Endocrine Tumors, ENDOC, Hamburg, Germany

7. 7School of Medicine, University of Belgrade, Belgrade, Serbia

8. 8Departments of Clinical Epidemiology and Endocrinology, Leids Universitair Medisch Centrum Ringgold Standard Institution, Leiden, Zuid-Holland, Netherlands

9. 9Fédération d’Endocrinologie, Centre de Référence des Maladies Rares Hypophysaires HYPO, Hospices Civils de Lyon, Bron, France

Abstract

The European Society of Endocrinology (ESE) survey reported on the largest cohort of 125 aggressive pituitary tumours (APT) and 40 pituitary carcinomas (PC). Whilst the survey focused on treatment effectiveness, all pathological data were not explored in detail. Here, we comment on some interesting pathological findings, notably the difference between APT and PC.

Publisher

Bioscientifica

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference10 articles.

1. Epidemiology and biomarker profile of pituitary adenohypophysial tumors.;Modern Pathology,2018

2. Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification;Journal of Clinical Endocrinology and Metabolism,2017

3. Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification;Journal of Clinical Endocrinology and Metabolism,2017

4. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up;Acta Neuropathologica,2013

5. Epidemiology and biomarker profile of pituitary adenohypophysial tumors.;Modern Pathology,2018

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors;Brain Pathology;2024-09

2. Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients;Minerva Endocrinology;2024-07

3. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations;Nature Reviews Endocrinology;2024-02-09

4. Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy;Cancers;2023-11-06

5. An update on, and genetics of refractory adenomas of childhood;Pituitary;2023-06